LifeTracDx (Clinical Trials)
Funding Details
- Awarder
- RSS - www.prnewswire.com
- Date Award
- May 30, 2025
- Vertical
- Healthcare
- Funding URL
- View Funding Page
Company Info
- Company Description
- LifeTracDx is focused on developing a blood test to monitor PD-L1 upregulation, which could support new treatment paths for metastatic triple negative breast cancer.
- Market
- Metastatic Triple Negative Breast Cancer
- Location
- USA